BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Boehringer Ingelheim
Baxter
Moodys
Johnson and Johnson
US Department of Justice
Fish and Richardson
Healthtrust
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050138

« Back to Dashboard

NDA 050138 describes BICILLIN C-R 900/300, which is a drug marketed by King Pharms Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the BICILLIN C-R 900/300 profile page.

The generic ingredient in BICILLIN C-R 900/300 is penicillin g benzathine; penicillin g procaine. There are eighty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
Summary for 050138
Tradename:BICILLIN C-R 900/300
Applicant:King Pharms Llc
Ingredient:penicillin g benzathine; penicillin g procaine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 050138
Ingredient-typePenicillins
Suppliers and Packaging for NDA: 050138
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BICILLIN C-R penicillin g benzathine; penicillin g procaine INJECTABLE;INJECTION 050138 NDA Physicians Total Care, Inc. 54868-5932 54868-5932-0 10 SYRINGE in 1 PACKAGE (54868-5932-0) > 2 mL in 1 SYRINGE
BICILLIN C-R penicillin g benzathine; penicillin g procaine INJECTABLE;INJECTION 050138 NDA Pfizer Laboratories Div Pfizer Inc 60793-600 60793-600-10 10 SYRINGE in 1 PACKAGE (60793-600-10) > 2 mL in 1 SYRINGE (60793-600-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength300,000 UNITS/ML;300,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength150,000 UNITS/ML;150,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength900,000 UNITS/2ML;300,000 UNITS/2ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Harvard Business School
Argus Health
US Army
Johnson and Johnson
Cantor Fitzgerald
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot